Brandon Couillard
Stock Analyst at Wells Fargo
(4.76)
# 137
Out of 4,732 analysts
100
Total ratings
66.22%
Success rate
21.94%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDNA CareDx | Upgrades: Equal-Weight | $28 → $24 | $21.44 | +11.94% | 2 | Jan 15, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $157 → $155 | $147.36 | +5.18% | 20 | Dec 9, 2024 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,350 | $1,295.43 | +4.21% | 2 | Nov 11, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $84 → $85 | $51.74 | +64.28% | 16 | Nov 6, 2024 | |
| BRKR Bruker | Maintains: Overweight | $78 → $75 | $56.88 | +31.86% | 2 | Nov 6, 2024 | |
| WAT Waters | Maintains: Overweight | $380 → $415 | $404.00 | +2.72% | 2 | Nov 4, 2024 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $34 → $75 | $69.48 | +7.94% | 2 | Oct 30, 2024 | |
| AVTR Avantor | Maintains: Overweight | $30 → $28 | $22.11 | +26.64% | 2 | Oct 28, 2024 | |
| TMO Thermo Fisher | Maintains: Overweight | $670 → $660 | $559.65 | +17.93% | 2 | Oct 24, 2024 | |
| MYGN Myriad Genetics | Initiates: Overweight | $35 | $12.39 | +182.49% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $160.51 | +12.14% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $4.77 | +109.64% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $139.61 | -14.05% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $341.00 | -0.29% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $342.41 | -0.70% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $130 | $118.39 | +9.81% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $280 | $238.36 | +17.47% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $74 → $81 | $73.22 | +10.63% | 5 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $19.83 | +15.99% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.93 | +573.58% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $450 | $224.23 | +100.69% | 10 | Oct 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.65 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $5.00 | +120.00% | 2 | Oct 13, 2017 |
CareDx
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $21.44
Upside: +11.94%
Agilent Technologies
Dec 9, 2024
Maintains: Overweight
Price Target: $157 → $155
Current: $147.36
Upside: +5.18%
Mettler-Toledo International
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $1,400 → $1,350
Current: $1,295.43
Upside: +4.21%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $51.74
Upside: +64.28%
Bruker
Nov 6, 2024
Maintains: Overweight
Price Target: $78 → $75
Current: $56.88
Upside: +31.86%
Waters
Nov 4, 2024
Maintains: Overweight
Price Target: $380 → $415
Current: $404.00
Upside: +2.72%
GeneDx Holdings
Oct 30, 2024
Maintains: Equal-Weight
Price Target: $34 → $75
Current: $69.48
Upside: +7.94%
Avantor
Oct 28, 2024
Maintains: Overweight
Price Target: $30 → $28
Current: $22.11
Upside: +26.64%
Thermo Fisher
Oct 24, 2024
Maintains: Overweight
Price Target: $670 → $660
Current: $559.65
Upside: +17.93%
Myriad Genetics
Aug 27, 2024
Initiates: Overweight
Price Target: $35
Current: $12.39
Upside: +182.49%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $160.51
Upside: +12.14%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $4.77
Upside: +109.64%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $139.61
Upside: -14.05%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $341.00
Upside: -0.29%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $342.41
Upside: -0.70%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $130
Current: $118.39
Upside: +9.81%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $280
Current: $238.36
Upside: +17.47%
Mar 6, 2024
Maintains: Hold
Price Target: $74 → $81
Current: $73.22
Upside: +10.63%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $19.83
Upside: +15.99%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.93
Upside: +573.58%
Oct 22, 2020
Maintains: Buy
Price Target: $355 → $450
Current: $224.23
Upside: +100.69%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.65
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $5.00
Upside: +120.00%